DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Q1 2022 13F-HR Holdings
Net value change ($000)
-294,635
(-6.2%)
New positions
12
Sold out positions
18
Turnover %
22.0%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q4 2021
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| SRPT | 116,124 | NEW |
| Horizon Therapeutics Public Ltd Co | 48,923 | NEW |
| GILD | 45,508 | NEW |
| NBIX | 38,059 | 32.4% |
| Silk Road Medical Inc | 24,280 | 37.6% |
| KURA | 21,822 | 44.4% |
| MIRM | 19,928 | 38.1% |
| GDRX | 18,926 | NEW |
| ImmunoGen, Inc. | 16,520 | NEW |
| BKD | 15,864 | 71.9% |
Top Reduces (Value $000, Stocks/ETFs)
| NUVL | -99,606 | -27.0% |
| Singular Genomics Systems, Inc. | -63,613 | -60.4% |
| AHCO | -63,363 | -25.3% |
| VTRS | -56,142 | -20.0% |
| Apria, Inc. | -53,979 | -100.0% |
| PTGX | -40,115 | -100.0% |
| LRMR | -39,295 | -62.5% |
| CNC | -36,089 | -43.6% |
| PCRX | -35,882 | -100.0% |
| GKOS | -30,248 | -58.6% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
2,613
(0.1% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|